United Therapeutics | UTHR - Umlaufvermögen

Aktienkurs
567.16
Täglich Wechseln
-5.69 -0.99%
Monatlich
4.72%
Jährlich
94.65%
Q2 Prognose
555.02




Umlaufvermögen Veränderung Datum
Amarin USD 649.88M 21.55M 2025-12
Ardelyx USD 382.32M 14.33M 2025-12
Baxter International USD 6.87B 61M 2025-12
Bayer EUR 32.91B 30M 2025-12
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
J&J USD 59.17B 3.55B 2026-03
Lexicon Pharmaceuticals USD 101.9M 20.63M 2025-12
Moderna USD 6.54B 54M 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12